Another molecule evaluated for the primary endpoint of the study was β2M, a polypeptide with a molecular weight of 11.8 kDa which has been extensively used as a marker for small middle molecule removal and which is associated with cardiovascular disease [12,37]. The gene discussed is B2M; the disease is cardiovascular disorder.